Proteonomix, Inc. Report issue

For profit Phase 2
Founded: Hawthorne NJ United States (1995)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2012
NCT01711073
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

plerixafor (mozobil) (2 trials)

sargramostim (leukine) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

End Stage Liver Disease (Phase 1)

Liver Diseases (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2